Experiences with
Ibrutinib2,003 public posts
Want to take advantage of all our features? Just log in!
or
BTK Inhibitor Therapy for CLL: An International Perspective - Stephan Stilgenbauer, MD
It also has been demonstrated that when patients develop atrial fibrillation or other ibrutinib-related AEs while receiving ibrutinib, ibrutinib can be discontinued and the patient can be switched to a second-generation BTK inhibitor.
Further evidence that even moderate exercise is good for your long term health - particularly when you have CLL!
[/i]https://insidemedicine.substack.com/p/weekend-warriors-vs-daily-gym-rats (no registration required)
While BTK inhibitor therapy with the 'inib drugs (acalabrutinib, ibrutinib and zanubrutinib, with pirtobrutinib and others on the way), has dramatically changed survival times with CLL, these treatments
Stem cell transplant starts on Monday
A bit of background - In October 2021 I had a rapid and florid relapse following the end of my Ibrutinib treatment in FLAIR so I was started on Acalabrutinib with no effect and also had investigations for Richter's.
Outcomes after UMRD with 1st line Ib +Ven Fixed Duration Treatment Versus Continued Ibr Follow-up in the CAPTIVATE Study
With additional follow-up in pts with confirmed uMRD after Ibr + Ven, 4-y OS rates were ≥98% and 4-y PFS rates were ≥88% in pts randomly assigned to fixed duration or continued Ibrutinib.